Quantcast

Latest Targeted therapy Stories

2014-03-25 12:29:41

Perjeta and Kadcyla are Reshaping the Treatment Algorithm for Patients with HER2-Positive Breast Cancer, According to Findings from Decision Resources Group BURLINGTON, Mass., March 25, 2014 /PRNewswire/ -- Decision Resources Group finds that efficacy more than any other factors drives oncologists' prescribing of targeted therapies for breast cancer and, according to the majority of surveyed oncologists, the escalating overall cost of drug treatment for breast cancer has little or no impact...

2014-03-24 23:27:51

Lead Candidate Provides Targeted and Personalized Medicine Approach to Lung Cancer Somerville, MA (PRWEB) March 24, 2014 ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for lung and neuroendocrine cancer announced today that P2045, the Company's lead candidate for targeted peptide therapy, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for the treatment of small cell lung cancer (SCLC). Orphan...

2014-03-17 12:27:23

Union Creates Global Leader In Targeted Oncolytic Immunotherapy BUSAN, South Korea and SAN FRANCISCO, March 17, 2014 /PRNewswire/ -- SillaJen, Inc., a privately-held biotherapeutics company focused on the development of targeted oncolytic immunotherapy products for cancer, announced today that it had completed the acquisition of San Francisco-based Jennerex, Inc. Privately-held Jennerex is a clinical-stage, biotherapeutics company recognized as a global leader in the development of...

2014-03-11 08:31:55

Global breast cancer survey demonstrates physicians generally prefer standard of care chemotherapy as compared to newly approved targeted therapies NEW YORK, March 11, 2014 /PRNewswire/ -- OBiS releases preliminary results from its 2014 global physician breast cancer survey. The survey included treatment data and insights from over 50 countries and 500 treating physicians. Data demonstrated that despite a number of newly approved targeted therapies, most physicians treated their...

New Combo Therapy Shows Promise For Cervical Cancer Treatment
2014-03-10 12:12:44

Bret Smith for redOrbit.com - Your Universe Online A team of Brazilian scientists has identified a promising new combination treatment that targets cervical cancer, according to a new report published in the journal Cancer. Patients with locally-advanced cervical cancer are typically prescribed cisplatin-based chemoradiation therapy (CRT), yet the benefits of this treatment have largely gone unresearched since the late 1990s, the study authors claimed. In search of a new treatment...

2014-03-05 10:44:37

By eliminating Mcl-1, radiation and chemotherapies could be more effective in treating the most common and deadly of all cancers Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments. Non-small cell lung cancer (NSCLC) makes up about 85 percent of the nearly 160,000 Americans expected to die this year from lung cancer, which by far...

2014-03-04 12:25:51

SAN DIEGO and OSAKA, Japan, March 4, 2014 /PRNewswire/ -- TRACON Pharmaceuticals (TRACON) and Santen Pharmaceutical Co., Ltd. (Santen) announced today that they have entered into an exclusive agreement for the development and global commercialization of TRACON's anti-endoglin antibodies, including TRC105, in ophthalmology. Pre-clinical and clinical data from TRACON's ongoing development of TRC105 in combination with anti-VEGF products in oncology indicate inhibiting both the...

2014-03-03 15:25:51

Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength. The research findings by UCLA's Jeffrey Zink, a professor of chemistry and biochemistry, and Fuyu Tamanoi, a professor of microbiology, immunology and molecular genetics, and their colleagues were...

2014-02-21 08:26:00

DALLAS, February 21, 2014 /PRNewswire/ -- RnRMarketResearch.com offers cancer monoclonal antibodies market (mABs) research reports covering pipeline analysis as well as monoclonal antibodies market forecasts in breast cancer, colorectal cancer as well as gastric and esophageal cancers to 2019. There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient's lifespan; Avastin, Erbitux and...

2014-02-20 23:24:59

The global market for antibody drug conjugates was valued at $179 million in 2012 and is estimated at $396 million for 2013. BCC Research projects the market to grow to nearly $2.8 billion by 2018, and register a five-year compound annual growth rate of 48.1% from 2013 to 2018. Wellesley, MA (PRWEB) February 20, 2014 According to a new technical market research report Antibody Drug Conjugates: Technologies and Global Markets, from BCC Research (http://www.bccresearch.com), the global...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.